143 results on '"Bernardini, Marcus Q."'
Search Results
2. Generation of an Inhibitory NK Cell Subset by TGF-β1/IL-15 Polarization
3. Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients withBRCAmutated advanced high grade serous ovarian cancer: 10 year survival analysis
4. Sustainability of an enhanced recovery pathway after minimally invasive gynecologic oncology surgery
5. Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma
6. Discovery and preliminary validation of a new panel of personalized ovarian cancer biomarkers for individualized detection of recurrence
7. Disturbed sleep is associated with reduced verbal episodic memory and entorhinal cortex volume in younger middle-aged women with risk-reducing early ovarian removal
8. Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy
9. A novel population of CD103-expressing CD56 +regulatory ILCs suppresses intratumoural T cells and are associated with poor prognosis in patients with ovarian carcinoma
10. Data from IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function
11. Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancer
12. Data from IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function
13. Supplementary Figures and Tables from IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function
14. Supplementary Figures and Tables from IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function
15. Data from Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome
16. Figure S6 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
17. Data from Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome
18. Supplemental Figure legends from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
19. Supplementary Tables S1-S3 from Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome
20. Figure S3 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
21. Figure S4 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
22. Figure S1 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
23. Figure S5 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
24. Supplemental Tables from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
25. Supplementary Tables S1-S3 from Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome
26. Figure S2 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
27. Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire
28. Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer
29. Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes
30. Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancer
31. Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer
32. Scene memory and hippocampal volume in middle-aged women with early hormone loss
33. Leiomyosarcoma
34. Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer
35. A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers
36. Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci
37. Implementation of a standardized voiding protocol after minimally invasive surgery: A quality improvement initiative
38. Extraocular sebaceous carcinoma arising in a mature cystic teratoma of ovary: A case report and review of literature
39. Endometrial Cancer: Transitioning from Histology to Genomics
40. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers
41. Enhanced recovery after minimally invasive gynecologic oncology surgery to improve same day discharge: a quality improvement project
42. Sensor detection in gynaecological medicine
43. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma
44. A prospective comparison of costs between robotics, laparoscopy, and laparotomy in endometrial cancer among women with Class III obesity or higher
45. Factors affecting surgical decision-making in carriers of BRCA1/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic
46. Treatment outcomes and predictive factors in patients ≥70 years old with advanced ovarian cancer
47. Implementation of a restrictive opioid prescription protocol after minimally invasive gynecologic oncology surgery
48. The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma
49. Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer
50. The Prevent Ovarian Cancer Program (POCP): Identification of Women at Risk for Ovarian Cancer Using Complementary Recruitment Approaches
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.